Magnetar Financial LLC Lowers Holdings in SiBone $SIBN

Magnetar Financial LLC decreased its position in SiBone (NASDAQ:SIBN) by 47.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,244 shares of the company’s stock after selling 9,417 shares during the period. Magnetar Financial LLC’s holdings in SiBone were worth $193,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of SIBN. American Century Companies Inc. increased its stake in SiBone by 11.1% during the 1st quarter. American Century Companies Inc. now owns 2,642,322 shares of the company’s stock valued at $37,072,000 after purchasing an additional 264,254 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of SiBone by 1.5% during the first quarter. Vanguard Group Inc. now owns 2,444,159 shares of the company’s stock valued at $34,292,000 after buying an additional 35,349 shares during the last quarter. First Light Asset Management LLC grew its holdings in shares of SiBone by 41.8% during the first quarter. First Light Asset Management LLC now owns 1,612,408 shares of the company’s stock valued at $22,622,000 after buying an additional 475,426 shares during the last quarter. Nuveen LLC bought a new stake in shares of SiBone during the first quarter valued at approximately $18,605,000. Finally, Harbor Capital Advisors Inc. raised its holdings in SiBone by 7.7% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 573,705 shares of the company’s stock worth $10,797,000 after acquiring an additional 40,993 shares during the last quarter. 98.11% of the stock is owned by hedge funds and other institutional investors.

SiBone Stock Performance

SIBN stock opened at $19.48 on Thursday. The company has a market cap of $845.24 million, a P/E ratio of -38.20 and a beta of 0.81. SiBone has a 1 year low of $12.49 and a 1 year high of $20.05. The company has a debt-to-equity ratio of 0.21, a current ratio of 7.97 and a quick ratio of 6.62. The stock’s fifty day moving average price is $15.86 and its 200-day moving average price is $16.82.

SiBone (NASDAQ:SIBN) last posted its quarterly earnings data on Monday, November 10th. The company reported ($0.11) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05. SiBone had a negative return on equity of 12.86% and a negative net margin of 11.24%.The company had revenue of $48.66 million during the quarter, compared to analysts’ expectations of $46.67 million. SiBone has set its FY 2025 guidance at EPS. On average, equities analysts forecast that SiBone will post -0.78 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have commented on SIBN. Cantor Fitzgerald set a $25.00 target price on SiBone and gave the company an “overweight” rating in a research note on Monday, August 11th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of SiBone in a report on Tuesday. Wall Street Zen cut SiBone from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Finally, Truist Financial decreased their target price on SiBone from $22.00 to $20.00 and set a “buy” rating for the company in a research report on Wednesday, October 15th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $23.00.

Insider Activity

In related news, insider Anthony J. Recupero sold 3,833 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $17.44, for a total transaction of $66,847.52. Following the completion of the sale, the insider directly owned 268,144 shares in the company, valued at approximately $4,676,431.36. The trade was a 1.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Laura Francis sold 5,411 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $17.70, for a total transaction of $95,774.70. Following the sale, the chief executive officer directly owned 351,319 shares of the company’s stock, valued at approximately $6,218,346.30. This represents a 1.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 127,128 shares of company stock worth $2,311,652. Company insiders own 4.00% of the company’s stock.

SiBone Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.